{"id":"NCT00522379","sponsor":"UCB Pharma","briefTitle":"Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch","officialTitle":"A Multicenter, Randomized, Double-blind, Placebo-controlled, 5-arm, Parallel-group Trial to Assess Rotigotine Transdermal System Dose Response in Subjects With Advanced-stage Parkinson's Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-07","primaryCompletion":"2011-07","completion":"2011-07","firstPosted":"2007-08-29","resultsPosted":"2012-12-10","lastUpdate":"2014-10-27"},"enrollment":514,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Parkinson's Disease"],"interventions":[{"type":"DRUG","name":"Rotigotine","otherNames":["Neupro"]},{"type":"DRUG","name":"Rotigotine","otherNames":["Neupro"]},{"type":"OTHER","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Rotigotine","otherNames":["Neupro"]},{"type":"DRUG","name":"Rotigotine","otherNames":["Neupro"]}],"arms":[{"label":"Rotigotine 2 mg/24 hr","type":"EXPERIMENTAL"},{"label":"Rotigotine 4 mg/24 hr","type":"EXPERIMENTAL"},{"label":"Rotigotine 6 mg/24 hr","type":"EXPERIMENTAL"},{"label":"Rotigotine 8 mg/24 hr","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to show Rotigotine dose response at four doses of Rotigotine used with L-dopa in treating advanced stage Parkinson's disease.","primaryOutcome":{"measure":"The Change in the Absolute Time Spent \"Off\" From Baseline to the End of the Maintenance Period as Recorded by the Subject in a Daily Diary","timeFrame":"From Baseline to the End of the Maintenance Period [16 Weeks Treatment Period (4 weeks Titration Period and 12 weeks Maintenance Period)].","effectByArm":[{"arm":"Rotigotine 2 mg/24 hr","deltaMin":-1.948,"sd":2.587},{"arm":"Rotigotine 4 mg/24 hr","deltaMin":-2.052,"sd":3.113},{"arm":"Rotigotine 6 mg/24 hr","deltaMin":-2.138,"sd":2.721},{"arm":"Rotigotine 8 mg/24 hr","deltaMin":-2.36,"sd":2.608},{"arm":"Placebo","deltaMin":-1.499,"sd":3.062}],"pValues":[]},"eligibility":{"minAge":"30 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":17},"locations":{"siteCount":77,"countries":["United States","Chile","India","Mexico","Peru"]},"refs":{"pmids":["26882318"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":101},"commonTop":["Nausea","Headache","Dizziness","Dyskinesia","Somnolence"]}}